STOCK TITAN

Aeluma (ALMU) SEC Filings, May-Jul 2026

ALMU NASDAQ

Aeluma, Inc. filings document the reporting record of a Nasdaq-listed emerging growth semiconductor company developing scalable photonic and electronic technologies. Its periodic and current reports cover financial results, quarterly reporting, Regulation FD materials, investor presentations and public-company disclosure controls.

The company’s SEC filings also describe capital-structure activity involving common stock, shelf registration, underwriting agreements and sales-agreement arrangements for registered equity issuance. Governance disclosures include annual meeting voting results, director elections and shareholder approvals, while other current reports address material definitive agreements and Rule 10b5-1 trading-plan disclosures.

Rhea-AI Summary

BlackRock, Inc. reported a passive ownership stake in AELUMA INC common stock. BlackRock beneficially owns 963,791 shares of Aeluma common stock, representing 5.3% of the outstanding class as of the reporting date.

BlackRock has sole voting power951,382 shares and sole dispositive power963,791 shares, with no shared voting or dispositive power. Various underlying clients and investors have rights to dividends or sale proceeds, but no single underlying holder has more than 5% of Aeluma’s outstanding common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.38%
Tags
ownership
-
Rhea-AI Summary

Aeluma, Inc. reports that CEO Jonathan Klamkin executed multiple common stock transactions on July 1, 2026. One bona fide gift disposition moved 20,000 shares held indirectly by a family trust, and a separate gift transaction recorded acquisition of 20,000 shares into his direct ownership.

He then sold 19,900 shares at a weighted average price of $21.081 per share in transactions priced between $20.54 and $21.52, plus an additional 100 shares at $21.56, in open market or private transactions. After these trades, he holds 2,403 shares of Aeluma common stock directly. Footnotes explain that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) director, officer and 10% stockholder Jonathan Klamkin filed a notice of a proposed sale of 40,000 common shares, with an approximate sale date of July 1, 2026, and an aggregate market value of $883,200.00. The notice lists two prior sales identified as 10b5-1 sales: 20,000 shares on June 1, 2026, for gross proceeds of $500,662.00, and 20,000 shares on May 1, 2026, for gross proceeds of $499,242.00. The notice gives December 3, 2025, as the plan adoption or instruction date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.05%
Tags
other
Rhea-AI Summary

Aeluma, Inc. Chief Executive Officer Jonathan Klamkin reported multiple insider transactions in the company’s common stock. On June 1, 2026, he sold a total of 20,000 shares in open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025.

The sales were executed in several tranches at weighted average prices of $22.19, $23.32, $24.39, $25.12 and $26.25 per share. He also made bona fide gifts totaling 40,000 shares, including 20,000 shares from his direct holdings and 20,000 shares from an indirect position held by a family trust.

Following these transactions, Klamkin directly holds 22,403 shares of Aeluma common stock and indirectly holds 1,366,995 shares through a family trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. director Steven Denbaars reported open-market sales of 25,000 shares of Common Stock. The sales occurred on May 19–20, 2026 at weighted average prices ranging from about $19.56 to $21.30 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025. Following these transactions, he directly holds 370,209 shares of Aeluma common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) director Steven DenBaars reported a proposed sale of 25,000 common shares, with an approximate sale date of May 19, 2026. The notice lists an aggregate market value of $519,000. It states that he acquired 25,000 shares from the issuer for cash on June 8, 2021, and lists November 20, 2025, as the date for a Rule 10b5-1 plan adoption or instruction.

It also reports sales of 12,500 shares on February 25, 2026, for gross proceeds of $219,765, and 12,500 shares on February 26, 2026, for gross proceeds of $198,093.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.66%
Tags
other
Rhea-AI Summary

Aeluma, Inc. furnished an updated investor presentation outlining its semiconductor photonics strategy and business position. The company highlights its Indium Gallium Arsenide (InGaAs) and large‑diameter wafer technology aimed at shortwave infrared sensing, AI infrastructure, datacom, defense, and quantum markets.

The deck notes recurring R&D revenue of $4 FY25, cash of about $37 as of 3/31/26, around 36 issued and pending patents, and more than 20 customer engagements, including sampling, NRE work and initial sales. Aeluma reports a 27-person team, capital‑light manufacturing that relies on partners, ISO 9001:2015 certification, and about 12k sq. ft. of facilities in Goleta, California with materials production and test capabilities.

The presentation frames large market opportunities in mobile and consumer SWIR sensors and AI data-center optical interconnects, citing substantial hyperscaler data-center capital spending and an industry shortage of indium phosphide substrates and fab capacity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.66%
Tags
current report
-
Rhea-AI Summary

Aeluma, Inc. reports an amended Schedule 13G/A showing reduced ownership. Mark N. Tompkins now reports 885,000 shares of Common Stock, representing 4.83% of the class based on May 8, 2026 outstanding shares. The amendment states this is an exit filing because the reporting person ceased to be a beneficial owner of more than 5%. The filing notes the reported percentage is calculated from 18,305,335 shares outstanding as of May 8, 2026 and that the reported amount includes the reporting person’s beneficial ownership as of March 31, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.49%
Tags
ownership
-
Rhea-AI Summary

Aeluma, Inc. reported higher revenue but a larger loss for the nine months ended March 31, 2026. Revenue rose to $3.9 million from $3.3 million, driven mainly by government contracts, while operating expenses more than doubled to $9.7 million as the company expanded headcount, materials purchases, and stock-based compensation.

Net loss widened to $5.1 million from $2.2 million, partly offset by other income of $668 thousand from interest on cash and investments. Cash, cash equivalents, and a certificate of deposit totaled $37.8 million as of March 31, 2026, up from $15.7 million, largely due to two underwritten equity offerings that raised net proceeds of $12.6 million and $23.4 million.

The company entered several new government contracts and had remaining performance obligations of $8.9 million, with revenue highly concentrated in U.S. government customers. Aeluma also put in place a $50 million at-the-market equity program that had not been utilized by quarter end. Management disclosed that disclosure controls and procedures remained ineffective due to limited finance staffing, although remediation efforts are underway.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.37%
Tags
quarterly report
Rhea-AI Summary

Aeluma, Inc. reported third quarter fiscal 2026 results showing modest revenue and ongoing investment-driven losses. Revenue for the three months ended March 31, 2026 was $1,222 thousand, while the company recorded a GAAP net loss of $1,800 thousand, or $(0.10) per basic and diluted share. For the nine-month period, revenue reached $3,879 thousand with a net loss of $5,146 thousand.

On a non-GAAP basis, which excludes items such as stock-based compensation and certain non-cash charges, Aeluma reported a third quarter net loss of $701 thousand and adjusted EBITDA of $(911) thousand. The company ended March 31, 2026 with $37,780 thousand in cash and cash equivalents, supporting its manufacturing and commercialization priorities.

Aeluma narrowed full fiscal 2026 revenue guidance to $4.2 million to $4.6 million, from a prior range of $4.0 million to $6.0 million, citing delays in contract execution related to government shutdowns and other factors. Management highlighted six new development engagements totaling $5 million and emphasized growing interest tied to AI data center and photonics demand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.37%
Tags
current report

FAQ

How many Aeluma (ALMU) SEC filings are available on StockTitan?

StockTitan tracks 83 SEC filings for Aeluma (ALMU), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aeluma (ALMU)?

The most recent SEC filing for Aeluma (ALMU) was filed on November 12, 2026.